Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Real world evidence

Why Many Clinical Trials Fail to Reflect Real Patients
Posted in
  • Industry Landscape

Why Many Clinical Trials Fail to Reflect Real Patients

Clinical trials are the backbone of pharmaceutical development, providing the critical data required for regulatory approval … Why Many Clinical Trials Fail to Reflect Real PatientsRead more

by Jayshree Gondane•March 5, 2026March 5, 2026•0
Why Real-World Evidence Matters More Than Ever in Pharma
Posted in
  • Digital Transformation
  • Industry Landscape

Why Real-World Evidence Matters More Than Ever in Pharma

The pharmaceutical industry is undergoing a fundamental shift in how evidence is generated, evaluated, and applied. … Why Real-World Evidence Matters More Than Ever in PharmaRead more

by Jayshree Gondane•February 27, 2026February 27, 2026•0
What Happens When Pharma Ignores Real-World Evidence
Posted in
  • Industry Landscape
  • Strategy & Execution

What Happens When Pharma Ignores Real-World Evidence

In 2023, nearly half of drugs approved by the U.S. Food and Drug Administration faced post-launch … What Happens When Pharma Ignores Real-World EvidenceRead more

by Jayshree Gondane•February 8, 2026February 8, 2026•0
Sales Acceleration Tactics for Orphan Drugs| orphan drug marketing
Posted in
  • Strategy & Execution

Sales Acceleration Tactics for Orphan Drugs| orphan drug marketing

Orphan drugs, designed to treat rare diseases affecting fewer than 200,000 patients in the United States, … Sales Acceleration Tactics for Orphan Drugs| orphan drug marketingRead more

by Jayshree Gondane•January 22, 2026January 22, 2026
Smart Messaging Frameworks for Chronic Disease Brands in the U.S. Pharmaceutical Market
Posted in
  • Digital Transformation
  • Regulatory Compliance

Smart Messaging Frameworks for Chronic Disease Brands in the U.S. Pharmaceutical Market

Chronic diseases represent a growing challenge in the United States, accounting for nearly 90% of annual … Smart Messaging Frameworks for Chronic Disease Brands in the U.S. Pharmaceutical MarketRead more

by Jayshree Gondane•January 22, 2026January 22, 2026•0
How Real-World Data Signals Are Reshaping Pharma Brand Positioning Strategies
Posted in
  • Digital Transformation
  • Industry Landscape
  • Strategy & Execution

How Real-World Data Signals Are Reshaping Pharma Brand Positioning Strategies

In 2023, the U.S. Food and Drug Administration reaffirmed its position that real-world evidence would continue … How Real-World Data Signals Are Reshaping Pharma Brand Positioning StrategiesRead more

by Jayshree Gondane•January 16, 2026January 16, 2026•0

Recent Posts

  • Voice AI in Pharma Patient Engagement: How Smart Speakers Are Changing Adherence, Access, and the Next Front Door of Healthcare
  • How AI Is Automating Pharma Content Supply Chains and Rewiring the Economics of Medical, Legal, and Commercial Content
  • Predictive Analytics for Pharma Product Launch Forecasting: The Commercial Intelligence System Deciding Which Drug Launches Win
  • AI for Real-World Evidence in Pharma Marketing: How Commercial Teams Turn Clinical Data Into Market Access, Physician Trust, and Revenue Growth
  • Digital Twins in Pharmaceutical Manufacturing and Marketing: How Real-Time Simulation Is Redefining Drug Production, Commercial Strategy, and Market Advantage

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A